Nusli Neville Wadia

SAT-appeal

• Appeal against SEBI's prolonged inaction or refusal to decide applications seeking exemption to enable re-classification as public shareholders of Citurgia Biochemicals Limited.
  SEBI shall consider the appellants' applications filed on 1 June 2020 and in 2024 in accordance with law. · SEBI shall decide the applications within an outer limit of eight weeks from 16 April 2025.
  Appeal: Appeal No. 162 of 2025, with Misc. Application No. 369 of 2025, disposed of by SAT on 16 April 2025.
• SAT matter SATV-152F04827B1ED2C729809BE9
  Intervener granted two weeks to file short submissions · Further hearing scheduled for 03 April 2025 at 2:30 p.m.
  Appeal: Appeal Nos. 838, 839, 840 and 1016 of 2022 were heard in part; further hearing fixed for 03 April 2025.
• SAT matter SATV-4CCD2AC59575FA180FF3C03B
  Order reserved after hearing appellants, respondent and intervenor · Written submissions, if any, may be supplied within a week from 30.10.2023
  Appeal: Appeal Nos. 838, 839, 840 and 1016 of 2022 with Misc. Applications 1789 and 1632 of 2022 heard on 30.10.2023, order reserved
• SAT matter SATV-BB7A939E06E33A4BAA08D8D6
  By consent, call / list matters on January 30, 2025 at 10:30 p.m.
  Appeal: Appeal Nos. 838, 839, 840 and 1016 of 2022 pending; Misc. Applications 1789/2022 and 1632/2022 pending; adjourned to 30.01.2025
• Alleged fraudulent misrepresentation of Bombay Dyeing financials by inflating sales Rs.2492.94 cr and profits Rs.1302.20 cr via flat sales to SCAL to avoid consolidation.
  Effect and operation of impugned WTM order stayed during pendency of appeals · Urgency applications disposed of
  Appeal: Appeal Nos. 838, 839 and 840 of 2022 with Misc. Applications 1353-1356, 1373-1374 of 2022 pending; stay granted on 10.11.2022, next date 10.01.2023
• SAT matter SATV-FE100F5F526F0D420ED0689F
  Arguments continuing; listed for further hearing on 28 April 2023 · Parties to act on digitally signed copy; certified copy available from Registry on payment
  Appeal: Appeal Nos. 838, 839, 840 and 1016 of 2022 pending; arguments continuing; next hearing 28 April 2023
• Alleged fraudulent MoUs between BDMCL and SCAL artificially inflated revenue (Rs.2492.94 cr, 56% of real estate revenue) and profits, misleading investors in violation of PFUTP.